Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study

被引:3434
作者
Wisplinghoff, H
Bischoff, T
Tallent, SM
Seifert, H
Wenzel, RP
Edmond, MB
机构
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
[2] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-5000 Cologne 41, Germany
关键词
D O I
10.1086/421946
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background. Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. Methods. Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. Results. Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P < .001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P < .001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. Conclusion. In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 42 条
[1]
The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients [J].
Bhorade, SM ;
Christenson, J ;
Pohlman, AS ;
Arnow, PM ;
Hall, JB .
CHEST, 1999, 115 (04) :1085-1091
[2]
BRYAN CS, 1983, REV INFECT DIS, V5, P629
[3]
Bacteremic pneumonia in neutropenic patients with cancer -: Causes, empirical antibiotic therapy, and outcome [J].
Carratalà, J ;
Rosón, B ;
Fernández-Sevilla, A ;
Alcaide, F ;
Gudiol, F .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (08) :868-872
[4]
Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients [J].
Collin, BA ;
Leather, HL ;
Wingard, JR ;
Ramphal, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) :947-953
[5]
PROSPECTIVE MULTICENTRIC STUDY OF THE ETIOLOGY OF 1051 BACTEREMIC EPISODES IN 782 CANCER-PATIENTS [J].
COULLIOUD, D ;
VANDERAUWERA, P ;
VIOT, M ;
LASSET, C .
SUPPORTIVE CARE IN CANCER, 1993, 1 (01) :34-46
[6]
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America SENTRY Antimicrobial Surveillance Program, 1997-2000 [J].
Diekema, DJ ;
Pfaller, MA ;
Jones, RN .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (06) :412-418
[7]
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[8]
Survey of infections due to Staphylococcus species:: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999 [J].
Diekema, DJ ;
Pfaller, MA ;
Schmitz, FJ ;
Smayevsky, J ;
Bell, J ;
Jones, RN ;
Beach, M .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S114-S132
[9]
The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive cave unit [J].
DiGiovine, B ;
Chenoweth, C ;
Watts, C ;
Higgins, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :976-981
[10]
Multicenter evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents in Puerto Rico [J].
Doern, GV ;
Jones, RN ;
Pfaller, MA ;
Erwin, M ;
Ramirez-Rhonda, C .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) :113-119